Skip to main content

Heidi ha levantado 65M$ en una serie B para acelerar el asistente de IA para médicos

Heidi AI
Iniciar sesiónObtén Heidi gratis

Pregúntale a la IA sobre Heidi:

Neurologist Template

Fampridine follow-up assessment

A professional Neurologist template for healthcare professionals.
Use this templateBrowse more templates
Browse more templates

About this template

This Fampridine Follow-up Assessment template is designed for neurologists to efficiently document patient progress on fampridine. It allows for the tracking of key metrics like 10-meter walk times, 9-Hole Peg Test results, and DSST scores. The template calculates improvement percentages and determines responder status, guiding treatment decisions. It also includes sections for clinical impressions, patient-reported benefits, and adverse events, ensuring a comprehensive record of the patient's response to the medication. This template helps streamline the assessment process, saving time and improving accuracy in neurological practice.

Preview template

FAMPRIDINE CLINIC – FOLLOW-UP ASSESSMENT ---------------------------------------- PATIENT DETAILS Full Name: John Smith DOB: 12/03/1960 (Age: 64) NHS Number: 1234567890 Hospital/CH No: CH12345 BASELINE MEASURES (Pre-treatment) 10m Walk: 12.5 sec 9HPT – Dominant: 25 sec 9HPT – Non-Dominant: 28 sec DSST: 45 CURRENT FOLLOW-UP MEASURES 10m Walk: 9.5 sec 9HPT – Dominant: 23 sec 9HPT – Non-Dominant: 26 sec DSST: 50 CALCULATED CHANGE 10m Walk Improvement: 24 % Responder threshold: ≥20% Responder status: Patient is a responder, continue fampridine. 9HPT – Dominant: 25 sec → 23 sec (Δ 8 %) 9HPT – Non-Dominant: 28 sec → 26 sec (Δ 7 %) DSST: 45 → 50 (Δ 11 %) CLINICAL IMPRESSION Mobility improvement noted: Patient reports improved walking speed and ease of movement. Patient-reported benefit: Patient states they feel more stable and confident when walking. Adverse events: No adverse events reported. CLINICIAN NOTES Patient demonstrates significant improvement in 10-meter walk time, indicating a positive response to fampridine. Other measures also show slight improvements. Patient reports subjective benefits. No adverse effects noted. Continue with current dosage and schedule follow-up in 3 months. DECISION Continue fampridine treatment. Schedule follow-up appointment in 3 months to reassess. Clinician: Dr. Emily Carter Date: 1 November 2024 ----------------------------------------
FAMPRIDINE CLINIC – FOLLOW-UP ASSESSMENT ---------------------------------------- PATIENT DETAILS "Full Name: " [patient's full name] (Only include if explicitly mentioned in transcript, context or clinical note, else omit section entirely.) "DOB: " [patient's date of birth] (Only include if explicitly mentioned in transcript, context or clinical note, else omit section entirely.) " (Age: " [patient's age] (Only include if explicitly mentioned in transcript, context or clinical note, else omit section entirely.)")" "NHS Number: " [patient's NHS number] (Only include if explicitly mentioned in transcript, context or clinical note, else omit section entirely.) "Hospital/CH No: " [patient's hospital or clinic number] (Only include if explicitly mentioned in transcript, context or clinical note, else omit section entirely.) BASELINE MEASURES (Pre-treatment) "10m Walk: " [baseline 10-meter walk time in seconds] (Only include if explicitly mentioned in transcript, context or clinical note, else omit section entirely.) " sec" "9HPT – Dominant: " [baseline 9-Hole Peg Test time for dominant hand in seconds] (Only include if explicitly mentioned in transcript, context or clinical note, else omit section entirely.) " sec" "9HPT – Non-Dominant: " [baseline 9-Hole Peg Test time for non-dominant hand in seconds] (Only include if explicitly mentioned in transcript, context or clinical note, else omit section entirely.) " sec" "DSST: " [baseline Digit Symbol Substitution Test score] (Only include if explicitly mentioned in transcript, context or clinical note, else omit section entirely.) CURRENT FOLLOW-UP MEASURES "10m Walk: " [current 10-meter walk time in seconds] (Only include if explicitly mentioned in transcript, context or clinical note, else omit section entirely.) " sec" "9HPT – Dominant: " [current 9-Hole Peg Test time for dominant hand in seconds] (Only include if explicitly mentioned in transcript, context or clinical note, else omit section entirely.) " sec" "9HPT – Non-Dominant: " [current 9-Hole Peg Test time for non-dominant hand in seconds] (Only include if explicitly mentioned in transcript, context or clinical note, else omit section entirely.) " sec" "DSST: " [current Digit Symbol Substitution Test score] (Only include if explicitly mentioned in transcript, context or clinical note, else omit section entirely.) CALCULATED CHANGE "10m Walk Improvement: " [calculated percentage improvement in 10-meter walk test] (Only include if explicitly mentioned in transcript, context or clinical note, else omit section entirely.) " %" "Responder threshold: ≥20%" "Responder status:" [responder status based on 10m walk improvement and threshold, with corresponding continuation or discontinuation advice for fampridine] (Only include if explicitly mentioned in transcript, context or clinical note, else omit section entirely.) "9HPT – Dominant: " [baseline 9-Hole Peg Test time for dominant hand] (Only include if explicitly mentioned in transcript, context or clinical note, else omit section entirely.) " → " [current 9-Hole Peg Test time for dominant hand] (Only include if explicitly mentioned in transcript, context or clinical note, else omit section entirely.) " (Δ ______ %)" "9HPT – Non-Dominant: " [baseline 9-Hole Peg Test time for non-dominant hand] (Only include if explicitly mentioned in transcript, context or clinical note, else omit section entirely.) " → " [current 9-Hole Peg Test time for non-dominant hand] (Only include if explicitly mentioned in transcript, context or clinical note, else omit section entirely.) " (Δ ______ %)" "DSST: " [baseline Digit Symbol Substitution Test score] (Only include if explicitly mentioned in transcript, context or clinical note, else omit section entirely.) " → " [current Digit Symbol Substitution Test score] (Only include if explicitly mentioned in transcript, context or clinical note, else omit section entirely.) " (Δ ______ %)" CLINICAL IMPRESSION "Mobility improvement noted: " [description of observed or reported mobility improvement] (Only include if explicitly mentioned in transcript, context or clinical note, else omit section entirely.) "Patient-reported benefit: " [description of patient's subjective report of benefit from treatment] (Only include if explicitly mentioned in transcript, context or clinical note, else omit section entirely.) "Adverse events: " [details of any adverse events reported by the patient] (Only include if explicitly mentioned in transcript, context or clinical note, else omit section entirely.) CLINICIAN NOTES [detailed notes from the clinician regarding the patient's assessment, progress, and relevant observations] (Only include if explicitly mentioned in transcript, context or clinical note, else omit section entirely.) DECISION [final decision regarding the patient's treatment plan, including rationale] (Only include if explicitly mentioned in transcript, context or clinical note, else omit section entirely.) "Clinician: " [name of the clinician] (Only include if explicitly mentioned in transcript, context or clinical note, else omit section entirely.) "Date: " [date of the assessment] (Only include if explicitly mentioned in transcript, context or clinical note, else omit section entirely.) ---------------------------------------- (Never come up with your own patient details, assessment, plan, interventions, evaluation, and plan for continuing care - use only the transcript, contextual notes or clinical note as a reference for the information included in your note. If any information related to a placeholder has not been explicitly mentioned in the transcript, contextual notes or clinical note, you must not state the information has not been explicitly mentioned in your output, just leave the relevant placeholder or omit the placeholder completely.) (Use as many lines, paragraphs or bullet points, depending on the format, as needed to capture all the relevant information from the transcript.)
Browse more templatesUse this template

How to use this template

Step 1: Download the template
1Step 1

Download the template

Get started by downloading the template to your device

Step 2: Customize to your needs
2Step 2

Customize to your needs

Tailor the template to match your specific requirements

Step 3: Deploy and share
3Step 3

Deploy and share

Implement your customized template and share with your team

Browse more templatesUse this template

Start practicing with a partner

Care is better with Heidi
Use this template

Specialty

Neurologist

Used

0 times

Type

Note

Last edited

6/1/2026

Created by

Javier Vicini

Related Templates

Note

Consulta de Seguimiento – Urología

Alexandra Blumer Romagni

Urologist, Spain

Note

Consulta Inicial – Urología

Alexandra Blumer Romagni

Urologist, Spain

Note

Primera Consulta de Neurología

Francisco Gilo Arrojo

Neurologist, Spain

Heidi AI

Heidi. A tu lado.

© 2026 Heidi. Todos los derechos reservados.

Especialidades

  • Medicina familiar

  • Especialidades

  • Salud mental

  • Fisioterapia

  • Dentistas

  • Veterinarios

  • Estudiantes

Cumplimiento normativo

  • Seguridad

  • Centro de seguridad

Producto

  • Tarifas

  • Guías de Heidi

  • Centro de ayuda

  • Estado del sistema

  • Requisitos del sistema

Sobre nosotros

  • Contáctanos

  • Empresa

  • Historias de clientes

  • Prensa

  • Puestos vacantes

    10+
  • Recursos humanos

Recursos

  • Blog

  • Calculadora ROI

  • Centro de recursos

  • Comunidad de plantillas

Legal

  • Política de privacidad

  • Términos de uso

  • Política de uso

  • Accesibilidad

  • Aviso legal